We offer a unique opportunity for innovative UK companies to familiarise themselves with the Life Sciences Sectors in both Spain and Portugal and to meet with key stakeholders.
- Welcome dinner/Country briefing
- A networking breakfast reception
- 1-2-1 meetings
- Possible site visit to a laboratoryPlease note the offer will potentially vary in each location to adapt to the local market.
24, 25 and 26 June 2019.
1-3 days depending on company.
Location: Lisbon, Madrid, Barcelona.
Cost: £250 (plus VAT) per location
You will be responsible for your travel and accommodation costs
Shona Brown (Madrid): firstname.lastname@example.org
Jessica Griffiths (Barcelona): email@example.com
Zelía Henriques (Lisbon): firstname.lastname@example.org
The productivity of the Spanish pharmaceutical sector is one of the highest among Spanish industry. It isinternationally competitive, exporting over 10,645 M€ annually. 20% of total R&D by industry is carried out in the pharmaceutical sector (900 M€). Strong clusters are present in Catalonia and Madrid.
Spain is the 5th largest European market for the pharmaceutical industry. The Spanish biotechnology sector isvibrant with most recent figures indicating over 100€ billion in sales. There are approximately 2900 companies involved in biotech related activities of which 1.078 are R+D related.
UK Products and services are considered to be of high quality, reliable and innovative. Regulation is well respected and reference to use in the NHS is valuable. Key themes include: innnovative solutions for digital health, diagnostics, OTC products, advanced therapeutics, oncology, drug discovery and drug development.
The Life Sciences sector has experienced an exponential growth in Portugal over the last decades.
The most prominent areas within Life Sciences and Biotech are linked to Pharma and Industrial applications for different manufacturing industries. Many businesses in this sector result from university-lead projects that successfully develop devices and products viable to be placed in the market, but there are also larger players, notably in the Pharmaceuticals sector.
Portuguese companies seek commercial and technological partnerships that are both cost effective and innovative, adding value to their projects in Portugal and overseas, as the majority operate in international markets.
The Portuguese Government continues to implement restructuring measures aimed at the sustainability of its NHS and the private sector players continue to expand their offer. Opportunities arise for suppliers of innovative cost efficient solutions. These include areas such as personalised medicine, chronic disease management, assisted living technologies, remote monitoring sensors, augmented reality for health applications, AI and analytics for health, wearable technology and new diagnosis solutions.
Places are limited and any interested company should send the questionnaire attached to the above emails no later than 30 April 2019.